T2EVOLVE

Interested in hearing about the latest developments in #CART? Hear T2EVOLVE Project Coordinator Michael Hudecek's interview in the European Hematology Association (EHA)  Unplugged podcast, discussing latest developments in the field. 🎙️ Find it on your podcast platform or here:

📢 Join us at the ESH 3rd Translational Research Conference! T2EVOLVE Project Coordinator Michael Hudecek will be co-chairing the conference focusing on Advanced Gene-Engineered Immune Cells alongside Chiara Bonini. Abstract submission for the conference is open until July 15:

Michael Hudecek will be presenting today on the latest achievements and outcomes of #T2EVOLVE. Make sure you don't miss it!!

#EHA2024 starts next week! You can hear more about T2EVOLVE on Sunday, June 16 during the European Projects in Hematology session from 8.30-9.30 AM. Project Coordinator Michael Hudecek will present all projects inside T2EVOLVE. For more info, see:

#T2EVOLVE got a fresh look! Curios? Visit our web page www.t2evolve.com and explore our exciting work in a shiny new format ✨️😀

🎉 We are thrilled to announce a new video on our T2EVOLVE Patient Hub! The video explains 3 steps to follow to find relevant and reliable information about CAR T-cell therapy online. T2EVOLVE would like to thank all members of the Working Group of Patients and Caregivers, and the patient advocacy groups Acute Leukemia Advocates Network, Lymphoma Coalition & Myeloma Patients Europe (MPE) for their essential contribution to the development of this video. Find it here:

💡 Are you interested in learning more about T2EVOLVE at #EBMT24? T2EVOLVE Scientific Project Manager Maik Luu will be presenting on 2 topics: 🕛 Apr 16, 11 AM: Future design of #CART 🕖 Apr 17, 1 PM: #T2EVOLVE - Standards, Harmonization and Education in the CAR T cell field

🔎 How can we speed up approval of cell and gene therapies in the EU? 🇪🇺 This article by Innovative Health Initiative (IHI) outlines the hurdles faced by manufacturers and key recommendations from T2EVOLVE's paper on how to accelerate development of T cell-therapies. Find it here:

In the realm of cutting-edge medical therapies, collaboration is not just a buzzword; it's the cornerstone of progress. Nowhere is this more evident than in the European landscape, where consortia have emerged as dynamic hubs for the advancement and faster accessibility of groundbreaking treatments involving Advanced Therapy Medicinal Products (ATMPs). These collaborations are not just fostering scientific advancement; they are reshaping the future of healthcare delivery. In this spirit, T2EVOLVE, supported by the GoCART coalition, recently organized two pivotal face-to-face workshops focused on addressing critical challenges in CAR-T manufacturing, specifically "Raw and Starting Material Challenges," as well as "Data Accessibility and Shareability" models that could create valuable collaborations between parties avoiding duplication and fostering unified approaches. We extend our heartfelt gratitude to the numerous consortia whose invaluable expertise and active participation have been instrumental in driving forward this initiative. Together, we are poised to revolutionize the landscape of therapeutic innovation and accessibility, ultimately transforming patients' lives across Europe and beyond! Stay tuned to see what comes next and get involved: www.t2evolve.com #T2EVOLVE #GOCART #IMSAVAR #AIDPATH #JOIN4ATMP #INNOCART #DARENL #CERTAINTY #IDERHA #SWECART #HARMONYALLIANCE #ihi

Thank you all for joining us at our Annual Consortium Meeting in Valencia! We look forward to the next opportunity to connect and learn from the different work packages. Find more photos and info about T2EVOLVE here: